Nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment.
CONCLUSION: This review is likely to enable a detailed insight on nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment and be of particular interest to pharmaceutical industry.
PMID: 29766787 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Fan M, Geng S, Liu Y, Wang J, Wang Y, Zhong J, Yan Z, Yu L Tags: Curr Pharm Des Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | Nanotechnology | PET Scan | Study